Evogene Profit Margin 2012-2021 | EVGN
Current and historical gross margin, operating margin and net profit margin for Evogene (EVGN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Evogene net profit margin as of June 30, 2021 is -2326.7%.
|Evogene Annual Profit Margins
|Evogene Quarterly Profit Margins
||Medical - Biomedical and Genetics
Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence, Evogene established its unique technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. Evogene holds a number of subsidiaries utilizing the CPB platform to develop human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production.